An observational study in Diabetes Mellitus, Cardiovascular Diseases (CVD) and Offspring, Adult, sponsored by China-Japan Friendship Hospital. Enrolling by invitation at 1 site in China. Per ClinicalTrials.gov, last updated 2025-05-06.
Sponsored by China-Japan Friendship Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 51 studies in Prediabetic State with a site in China — 24 open to participants now, 25 under way, 1 of them phase 3. Prediabetic State · China.
Among the 51 studies in Prediabetic State with a site in China, this one is one of 10 that started in 2025, is one of 7 observational ones, reaches primary completion later than 8 of the 24 other live ones, and was the 39th registered.
919 studies on the registry are indexed under Prediabetic State; 231 are open to participants now.
Browse Prediabetic State studies →24 of the 51 studies in Prediabetic State with a site in China are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in China, United States, Argentina and 9 more countries
Ages 18+
Yang Zhang · Sites in China
Ages 60–79
Zhujiang Hospital · Sites in China
Ages 18–60
Beijing Anzhen Hospital · Sites in China
Ages 18+ · Healthy volunteers
Hudson Biotech · Sites in China
Ages 18–65
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 144 Prediabetic State studies recruiting now, 51 (35%) set no upper age limit and 83 (58%) stop at 75 or younger; 12 take children under 18; 54 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
51 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 3 · Phase 4 8
First in 2008; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 5,000 is above the median of 224 across 129 observational studies indexed under Prediabetic State.
Median enrollment 160 across the 44 interventional studies, 2,800 across the 7 observational. Of the 15 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 51 have an industry lead sponsor. The 10 most frequent:
China-Japan Friendship Hospital is the lead sponsor of 179 studies on the registry; 112 are open to participants now.
China-Japan Friendship Hospital has 2 studies filed under Prediabetic State — fewer than ten, so there is no comparison to draw.
12 of the studies in Prediabetic State with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06448130Shandong Provincial HospitalHenagliflozin's Impact on Prediabetes Remission | 2026-12 |
| NCT07289880The First Affiliated Hospital of Guangdong Pharmaceutical UniversityEfficacy of Diacylglycerol Oil on Metabolic Risk Factors in Prediabetes | 2026-12-01 |
| NCT05749874China National Center for Cardiovascular DiseasesEffects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus | 2026-12-31 |
| NCT06958640China-Japan Friendship HospitalDa Qing Offspring Study | 2026-12-31 |
| NCT07271745Chunyan MaMulticenter Study on Early Arterial Changes in Prediabetic Patients Evaluated by Ultra-High-Frequency Ultrasound | 2026-12-31 |
Add all 12 to your calendar (.ics) → With an account.
Among the 51 studies in Prediabetic State with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is an observational study tracking families and offspring of three cohorts from the 1986 Da Qing study: newly diagnosed diabetes, impaired glucose tolerance, and normoglycemia groups. Based on the original participants, the study will further include their spouses, first to third-generation offspring, and spouses of the offspring. General demographic information will be collected, and anthropometric measurements will be refined. A structured questionnaire will be used to gather disease history, family history of diabetes, and related information. Comprehensive diabetes-related laboratory screening and complication assessments will be conducted. A standardized biobank will be established, including blood and urine samples from the Da Qing Offspring Study, to support future research on epigenetics, metabolomics, and other mechanisms.
919 studies on the registry are indexed under Prediabetic State; 231 are open to participants now.
This study's planned enrollment of 5,000 is above the median of 224 across 129 observational studies indexed under Prediabetic State.
Browse Prediabetic State studies →China-Japan Friendship Hospital is the lead sponsor of 179 studies on the registry; 112 are open to participants now.
Compared within Prediabetic State, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Diabetes Mellitus. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Original subjects and spouses (70-90 years old), N=576+576=1152; First generation (50-70 years old), based on an average of 3 children per family, N=576*3=1728; The marriage rate of first generation is 90%, and the spouses N=1555; Second generation (25-45 years old), based on 90% of families having children, with an average of 1 child per family, N=1555*90%*1=1400; The marriage rate of second generation is 70%, and the spouses N=1400*70%=980; Third generation (1-20 years old), based on 80% of families having children, with an average of 1 child per family, N=980*80%*1=784; Based on the follow-up rate of 70%, the total number of people is about 5,000.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
▪People who are unwilling to participate in this study
The subjects who received lifestyle intervention in the original Daqing Diabetes Prevention Study, their spouses, children 1 to 3, and spouses of their offspring were included in the study.
Behavioral: Lifestyle interventions
The subjects who did not received lifestyle intervention in the original Daqing Diabetes Prevention Study, their spouses, children 1 to 3, and spouses of their offspring were included in the study.
Dietary intervention: 30kcal energy intake per kilogram of body weight per day, increase vegetable intake, control sugar and alcohol intake, encourage overweight and obese people to lose weight, lose 0.5-1kg per month until the weight reaches the target. Exercise intervention: Appropriate physical activity in spare time, 30-40 minutes per day, 5 times a week.
Cumulative incidence rate of diabetes
This study statistically analyzed the cumulative incidence rate of diabetes at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
weight
The subject's weight is recorded and the results are reported in kilograms.
Time frame: Through study completion, an average of about 1.5 years
waist circumference
The subjects' waist circumference was recorded and the waist circumference results were reported in centimeters.
Time frame: Through study completion, an average of about 1.5 years
Height
The subject's height was recorded, and the results were recorded in centimeters.
Time frame: Through study completion, an average of about 1.5 years
Exercise frequency and intensity
The subjects' daily exercise frequency and intensity were recorded.
Time frame: Through study completion, an average of about 1.5 years
Coronary heart disease incidence
This study statistically analyzed the incidence of coronary heart disease at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
all-cause deaths
This study counted all-cause deaths at the end of the study through death certificate, medical record review, family interview
Time frame: Through study completion, an average of about 1.5 years
incidence of diabetic peripheral neuropathy
This study statistically analyzed the incidence of diabetic peripheral neuropathy at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
other cause mortality
This study statistically analyzed other cause mortality at the end of the study through death record, medical record review, family interview
Time frame: Through study completion, an average of about 1.5 years
cardiovascular mortality rate
This study statistically analyzed the cardiovascular mortality rate at the end of the study through death certificate, medical record review, family interview
Time frame: Through study completion, an average of about 1.5 years
incidence of blindness
This study statistically analyzed the incidence of blindness at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
Diabetic retinopathy incidence
This study statistically analyzed the incidence of diabetic retinopathy at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
Diabetic nephropathy incidence
This study statistically analyzed the incidence of diabetic nephropathy at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
Peripheral vascular disease incidence
This study statistically analyzed the incidence of peripheral vascular disease at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
Heart failure incidence
This study statistically analyzed the incidence of heart failure at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
Stroke incidence
This study statistically analyzed the incidence of stroke at the end of the study through interview, medical record review, physical examination
Time frame: Through study completion, an average of about 1.5 years
dietary habits
The subjects' eating habits and dietary preferences were assessed through patient interviews.
Time frame: Through study completion, an average of about 1.5 years
health-related quality of life
The EuroQol questionnaire or health status questionnaire was administered through patient interviews to assess the subjects' health-related quality of life.
Time frame: Through study completion, an average of about 1.5 years
blood pressure
During the visit, the subjects' systolic and diastolic blood pressures were measured at rest by physical examination. The measurements were performed twice and the average was taken.
Time frame: Through study completion, an average of about 1.5 years
blood sugar
Blood samples were collected from the subjects at 1 hour and 2 hours after the steamed bread meal when they were fasting. The blood samples were used to test blood sugar levels and blood lipids, including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol.
Time frame: Through study completion, an average of about 1.5 years
blood lipid
Venous blood was collected from the subjects in a fasting state. The blood samples were used to test blood lipid status, including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol.
Time frame: Through study completion, an average of about 1.5 years
skin AGE
The skin AGE of the subjects was measured by physical examination. After cleaning the inner skin of the forearm, the AGE Reader probe was gently placed on the skin surface, the excitation light was emitted and the fluorescence intensity was recorded. The results were repeated 3 times and the average value was taken.
Time frame: Through study completion, an average of about 1.5 years
Tidal Volume
The subjects were assessed for Tidal Volume, which reflects the ventilation efficiency in the basic breathing state. Tidal Volume is measured in liters.
Time frame: Through study completion, an average of about 1.5 years
Functional Residual Capacity
Subjects were assessed for Functional Residual Capacity, which reflects lung capacity. Functional Residual Capacity is measured in liters.
Time frame: Through study completion, an average of about 1.5 years
Forced Vital Capacity
The subjects were assessed for Forced Vital Capacity, which reflects the overall ventilation capacity of the lungs. Forced Vital Capacity is measured in liters.
Time frame: Through study completion, an average of about 1.5 years
Forced Expiratory Volume in 1 second
The subjects were assessed for Forced Expiratory Volume in 1 second, which reflects respiratory reserve capacity. Forced Expiratory Volume in 1 second is measured in liters.
Time frame: Through study completion, an average of about 1.5 years
Plan to share: Undecided
Started Apr 2025 (actual). Primary completion is estimated for Dec 2026, 20 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China-Japan Friendship Hospital →